Glaukos (GKOS) Enterprise Value (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.80% |
| Dec 31, 2025 | 7.57% |
| Sep 30, 2025 | 2.55% |
| Jun 30, 2025 | 11.76% |
| Mar 31, 2025 | 32.64% |
| Dec 31, 2024 | -69.38% |
| Sep 30, 2024 | -47.11% |
| Jun 30, 2024 | -60.20% |
| Mar 31, 2024 | 54.53% |
| Dec 31, 2023 | 14.19% |
| Sep 30, 2023 | -14.89% |
| Jun 30, 2023 | -24.10% |
| Mar 31, 2023 | 36.08% |
| Dec 31, 2022 | -14.91% |
| Sep 30, 2022 | -1.43% |
| Jun 30, 2022 | 3.44% |
| Mar 31, 2022 | -5.46% |
| Dec 31, 2021 | 10.98% |
| Sep 30, 2021 | 4.37% |
| Jun 30, 2021 | -22.43% |
| Mar 31, 2021 | -0.03% |
| Dec 31, 2020 | -19.26% |
| Mar 31, 2020 | -85.12% |
| Dec 31, 2019 | -57.91% |
| Sep 30, 2019 | 1.15% |
| Jun 30, 2019 | -18.74% |
| Mar 31, 2019 | -12.94% |
| Dec 31, 2018 | 73.54% |
| Sep 30, 2018 | -351.88% |
| Jun 30, 2018 | 75.08% |
| Mar 31, 2018 | -308.31% |
| Dec 31, 2017 | -26.87% |
| Sep 30, 2017 | -44.49% |
| Jun 30, 2017 | -54.55% |
| Mar 31, 2017 | -33.22% |
| Dec 31, 2016 | -30.19% |
| Sep 30, 2016 | 59.58% |
| Jun 30, 2016 | -18.74% |
| Mar 31, 2016 | 51.83% |
| Dec 31, 2015 | 76.89% |
| Sep 30, 2015 | 10.38% |
| Jun 30, 2015 | -2,356.81% |
| Mar 31, 2015 | 64.41% |
| Dec 31, 2014 | -450.32% |
| Sep 30, 2014 | -2.27% |